A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: certificate (68), licence (138), tag (10)

Elranatamab

Description
Chemotherapy Protocol ELRANATAMAB This protocol may require funding Regimen • Elranatamab Indication • Monotherapy for th
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Elranatamab-Ver2.pdf

Where to eat, drink and shop

Description
Where to eat, drink and shop Location: C level, main entrance, Southampton General Hospital Open Monday to Sunday, 6am
Url
/Media/UHS-website-2019/Docs/For-visitors/Where-to-eat-drink-and-shop.pdf

AtezolizumabSC Bevacizumab Carboplatin Paclitaxel

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ATEZOLIZUMAB-SC-BEVACIZUMAB-CARBOPLATIN (AUC6)-PACLITAXEL Regimen • Lung-Atezolizumab-S
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/AtezolizumabSC-Bevacizumab-Carboplatin-Paclitaxel-Ver1.0.pdf

Atezolizumab SC-Carboplatin(AUC5)-Etoposide (IV/PO)

Description
Chemotherapy Protocol LUNG CANCER– SMALL CELL (SCLC) ATEZOLIZUMAB-SC-CARBOPLATIN (AUC5)-ETOPOSIDE(IV/PO) Regimen • Lung - AtezolizumabSC-Carbo
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Atezolizumab-SC-CarboplatinAUC5-Etoposide-IVPO.pdf

Papers Trust Board - 29 November 2022

Description
Date Time Location Chair Agenda Trust Board – Open Session 29/11/2022 9:00 - 13:20 Conference Room, Heartbeat/Microsoft Teams
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Papers-Trust-Board-29-November-2022.pdf

Atezolizumab-Bevacizumab-Carboplatin(AUC6)-Paclitaxel

Description
Chemotherapy Protocol LUNG CANCER ATEZOLIZUMAB-BEVACIZUMAB-CARBOPLATIN (AUC6)-PACLITAXEL Regimen  Lung-Atezolizumab-Bevacizumab-Carboplatin (AUC6
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Atezolizumab-Bevacizumab-CarboplatinAUC6-Paclitaxel.pdf

Annual-report-and-quality-account-2019-20

Description
ANNUAL REPORT AND ACCOUNTS 2019/20 Incorporating the quality account 2019/20 Page 2 University Hospital Southampton NHS Foundation Trust Annual
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-and-quality-account-2019-202.pdf

Vinblastine Ver 1.1

Description
Chemotherapy Protocol LYMPHOMA VINBLASTINE Regimen Lymphoma – Vinblastine Indication Non-Hodgkin’s L
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Vinblastine-Ver-1.1.pdf

1607TalimogeneRx108PFU (2)

Description
TALIMOGENE 108PFU/ml for MELANOMA INITIAL PRESCRIPTION – Second and Subsequent ADMINISTRATIONS ONLY Please Attach Addressograph Patient Information Card Yes / No (please
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/1607TalimogeneRx108PFU-2.pdf

1607TalimogeneRx106PFU (2)

Description
TALIMOGENE 106 PFU/ml for MELANOMA INITIAL PRESCRIPTION – FIRST ADMINISTRATION ONLY Please Attach Addressograph Patient Information Card Yes / No (please circle
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/1607TalimogeneRx106PFU-2.pdf
31 to 40 of 192
Previous … 2 3 4 5 6 … Next